https://www.vvmf.com.au/vvmf-announces-the-appointment-of-mr-stephen-thompson-as-the-inaugural-chief-executive-officer/2024-08-08T12:25:36+10:00https://www.vvmf.com.au/vvmf-announces-appointment-of-the-board/2024-08-08T13:34:04+10:00https://www.vvmf.com.au/diversity-disclosure-2023-2024/2024-08-08T13:37:18+10:00https://www.vvmf.com.au/viral-vector-manufacturing-facility-vvmf-at-bio-korea-2025/2025-04-22T09:42:26+10:00https://www.vvmf.com.au/viral-vector-manufacturing-facility-vvmf-at-bio-international-conference-2025/2025-05-21T11:54:36+10:00https://www.vvmf.com.au/viral-vector-manufacturing-facility-vvmf-and-cell-therapies-enters-strategic-collaboration/2025-07-15T17:11:20+10:00https://www.vvmf.com.au/diversity-disclosure-2024-2025/2025-09-04T14:24:03+10:00https://www.vvmf.com.au/viral-vector-manufacturing-facility-vvmf-at-the-cell-gene-meeting-on-the-mesa-2025/2025-09-23T09:31:00+10:00https://www.vvmf.com.au/viral-vector-manufacturing-facility-vvmf-and-chimeric-therapeutics-sign-letter-of-intent-to-provide-gmp-manufacturing-of-viral-vectors-in-australia-for-global-clinical-applications/2025-10-16T17:36:40+11:00https://www.vvmf.com.au/australias-first-clinical-and-commercial-scale-viral-vector-cdmo-vvmf-opens-in-sydney/2025-10-28T10:06:51+11:00https://www.vvmf.com.au/vvmf-announces-strategic-collaboration-with-oxb-with-view-to-licencing-aav-and-lentiviral-vector-platforms-as-first-priority/2026-02-11T11:03:39+11:00https://www.vvmf.com.au/viral-vector-manufacturing-facility-vvmf-at-advanced-therapies-week-2026-san-diego/2026-02-03T15:41:50+11:00https://www.vvmf.com.au/viral-vector-manufacturing-vvmf-enters-into-licensing-agreement-with-oxb-gaining-access-to-the-oxb-aav-and-lv-viral-vector-platforms/2026-03-18T18:24:13+11:00https://www.vvmf.com.au/viral-vector-manufacturing-facility-vvmf-to-attend-arms-cell-and-gene-meeting-on-the-med-2026/2026-04-17T16:19:56+10:00